| 2024-04-25 12:45 | CC:NRX | Nurexone Biologic Inc | 0.63 | News Release200 | Nurexone Biologic begins trading on OTCQB |
| 2024-04-02 13:17 | CC:NRX | Nurexone Biologic Inc | 0.78 | News Release200 | Nurexone spends $1.54-million (U.S.) on R&D in 2023 |
| 2024-04-02 08:53 | CC:NRX | Nurexone Biologic Inc | 0.78 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-04-02 08:18 | CC:NRX | Nurexone Biologic Inc | 0.78 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-03-27 17:18 | CC:NRX | Nurexone Biologic Inc | 0.76 | News Release200 | Nurexone receives $3.95-million from warrant exercise |
| 2024-03-22 17:17 | CC:NRX | Nurexone Biologic Inc | 0.65 | News Release200 | Nurexone signs deal with Vivox to test Exopten |
| 2024-03-15 16:12 | CC:NRX | Nurexone Biologic Inc | 0.74 | News Release200 | Nurexone shares to list on OTCQB Venture Market |
| 2024-03-08 16:11 | CC:NRX | Nurexone Biologic Inc | 0.82 | News Release200 | Nurexone finalizes lease for Israeli R&D facility |
| 2024-02-20 16:27 | CC:NRX | Nurexone Biologic Inc | 1.09 | News Release200 | Nurexone expands IP portfolio with ExoTherapy platform |
| 2024-02-14 16:34 | CC:NRX | Nurexone Biologic Inc | 0.48 | News Release200 | Nurexone to try to license ExoTherapy |
| 2024-02-02 16:14 | CC:NRX | Nurexone Biologic Inc | 0.305 | News Release200 | Nurexone starts European regulatory process for ExoPTEN |
| 2024-01-17 13:20 | CC:NRX | Nurexone Biologic Inc | 0.265 | News Release200 | Nurexone begins spinal cord research with Inteligex |
| 2024-01-16 18:58 | CC:NRX | Nurexone Biologic Inc | 0.265 | Private Placement250 | Nurexone Biologic 7,091,993-share private placement |
| 2024-01-05 09:37 | CC:NRX | Nurexone Biologic Inc | 0.295 | News Release200 | Nurexone closes $1.98-million private placement |
| 2023-11-29 14:25 | CC:NRX | Nurexone Biologic Inc | 0.31 | News Release200 | Nurexone Biologic develops 2 RNA sequences |
| 2023-11-24 09:51 | CC:NRX | Nurexone Biologic Inc | 0.31 | News Release200 | Nurexone spends $400,000 (U.S.) on R&D in Q3 2023 |
| 2023-11-24 08:08 | CC:NRX | Nurexone Biologic Inc | 0.31 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-24 08:06 | CC:NRX | Nurexone Biologic Inc | 0.31 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-10-30 09:33 | CC:NRX | Nurexone Biologic Inc | 0.31 | News Release200 | Nurexone receives orphan drug designation for ExoPTEN |
| 2023-10-19 13:32 | CC:NRX | Nurexone Biologic Inc | 0.295 | News Release200 | Nurexone adds Dagi to scientific advisory board |
| 2023-10-11 12:00 | CC:NRX | Nurexone Biologic Inc | 0.26 | News Release200 | Nurexone to receive $350,000 grant in Israel |
| 2023-09-28 18:58 | CC:NRX | Nurexone Biologic Inc | 0.23 | Private Placement250 | Nurexone Biologic 5,394,548-share private placement |
| 2023-09-28 18:45 | CC:NRX | Nurexone Biologic Inc | 0.23 | Miscellaneous270 | Nurexone Biologic 12,682,340 warrants repriced |
| 2023-09-28 13:20 | CC:NRX | Nurexone Biologic Inc | 0.23 | News Release200 | Nurexone hires Dr. Reuter for European IR services |
| 2023-09-13 10:35 | CC:NRX | Nurexone Biologic Inc | 0.22 | News Release200 | Nurexone completes ExoPTEN pre-IND meeting with FDA |
| 2023-09-06 14:30 | CC:NRX | Nurexone Biologic Inc | 0.22 | News Release200 | Nurexone closes $206,250 final tranche of financing |
| 2023-08-28 12:09 | CC:NRX | Nurexone Biologic Inc | 0.22 | News Release200 | Nurexone spends $460,000 (U.S.) on R&D in Q2 2023 |
| 2023-08-28 08:40 | CC:NRX | Nurexone Biologic Inc | 0.22 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-28 08:38 | CC:NRX | Nurexone Biologic Inc | 0.22 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-08-09 13:51 | CC:NRX | Nurexone Biologic Inc | 0.28 | News Release200 | Nurexone arranges 27.5-cent-per-unit private placement |
| 2023-07-20 14:34 | CC:NRX | Nurexone Biologic Inc | 0.28 | News Release200 | Nurexone talks extracellular vesicles technology |
| 2023-07-07 11:16 | CC:NRX | Nurexone Biologic Inc | 0.275 | News Release200 | Nurexone Biologic appoints Riesenfeld as director |
| 2023-06-22 10:21 | CC:NRX | Nurexone Biologic Inc | 0.24 | News Release200 | Nurexone details ExoPTEN image analysis results |
| 2023-06-01 11:06 | CC:NRX | Nurexone Biologic Inc | 0.25 | News Release200 | Nurexone receives NTA tool from Particle Metrix |
| 2023-05-24 12:56 | CC:NRX | Nurexone Biologic Inc | 0.30 | News Release200 | Nurexone spends $370,000 (U.S.) on R&D in Q1 |
| 2023-05-24 08:36 | CC:NRX | Nurexone Biologic Inc | 0.30 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-24 08:36 | CC:NRX | Nurexone Biologic Inc | 0.30 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-16 10:33 | CC:NRX | Nurexone Biologic Inc | 0.32 | News Release200 | Nurexone Biologic receives U.S. patent for ExoPTEN |
| 2023-05-12 12:22 | CC:NRX | Nurexone Biologic Inc | 0.32 | News Release200 | Nurexone Biologic hires Litchfield for IR services |
| 2023-05-08 13:06 | CC:NRX | Nurexone Biologic Inc | 0.28 | News Release200 | Nurexone Biologic director Flom resigns |